Pediatric ACL: Understanding Treatment Options

Trial ID or NCT#

NCT02772770

Status

recruiting iconRECRUITING

Purpose

Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature patients.

Official Title

Pediatric ACL: Understanding Treatment Options (PLUTO)

Eligibility Criteria

Ages Eligible for Study: 5 Years to 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. - Diagnosis of complete intrasubstance ACL tear - Skeletally Immature (by knee radiographs)
Exclusion Criteria:
  1. - Prior ACL surgery on the ipsilateral knee - Congenital ACL deficiency - Multiple ligament reconstruction required - Other significant comorbidities including syndromic conditions, neuromuscular disorders or developmental delay - If scheduling of the ACL surgery is impacted by the skeletal maturity of the patient - Simultaneous bilateral ACL tears

Investigator(s)

Kevin Shea
Pediatric orthopaedic surgeon, Sports medicine surgeon
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics

Contact us to find out if this trial is right for you.

Contact

Steven Frick, MD